Reckitt Benckiser Healthcare (UK) Limited
- Address
- Dansom Lane
Sponsor Overview
Specializations
Healthy volunteer research
Clinical research activity is focused on healthy volunteers, with attention to human tolerance and skin irritation assessment in a controlled volunteer setting.
- Cumulative irritation patch testing
- Dermal tolerability
- Cutaneous exposure assessment
The sponsor’s current trial activity is centred in the United Kingdom, with research conducted through a single collaborating site in Hull.
Dermatological safety
Research interest includes evaluation of skin compatibility and local reaction profiles for products intended for external use.
- Patch application studies
- Skin response monitoring
- Topical product tolerability
This area reflects a focus on dermatology-related safety endpoints rather than disease treatment.
Consumer health product evaluation
The sponsor is engaged in research supporting the assessment of over-the-counter and other consumer healthcare products, with emphasis on user safety and acceptability.
- Product tolerability
- Human skin exposure
- Safety screening in volunteers
Its funded activity is aligned with pharmaceutical development interests in non-therapeutic safety evaluation.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Cumulative Irritation Assessment of Topical Formulations in Healthy Volunteers: A Patch Test Study | Germany | Not Recruiting |
Data & Insights
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 1 site across their trial portfolio.
Therapeutic Focus
- 1.Not possible to specify1 trial220 other sponsors
Partnered Research Centres
1 centre- Address
- Kiebitzweg 2, 22869 Schenefeld
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Reckitt Benckiser Healthcare (UK) Limited.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.

